Lulu Ni

555 total citations
25 papers, 434 citations indexed

About

Lulu Ni is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Lulu Ni has authored 25 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Pharmacology. Recurrent topics in Lulu Ni's work include Berberine and alkaloids research (5 papers), Ginseng Biological Effects and Applications (3 papers) and Cancer Mechanisms and Therapy (3 papers). Lulu Ni is often cited by papers focused on Berberine and alkaloids research (5 papers), Ginseng Biological Effects and Applications (3 papers) and Cancer Mechanisms and Therapy (3 papers). Lulu Ni collaborates with scholars based in China and United States. Lulu Ni's co-authors include Min Ai, Weipao Miao, Chun Li, Qingsong Liu, Chenyuan Gong, Xiaowen Zhu, Bao Hou, Liying Qiu, Shiguo Zhu and Yuetao Zhou and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Lulu Ni

25 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lulu Ni China 13 159 75 62 61 55 25 434
Yinghong Li China 15 212 1.3× 115 1.5× 56 0.9× 43 0.7× 30 0.5× 46 604
Chengzhen Li China 10 110 0.7× 67 0.9× 52 0.8× 38 0.6× 9 0.2× 31 361
Byeong-Soo Kim South Korea 9 132 0.8× 69 0.9× 36 0.6× 16 0.3× 12 0.2× 12 405
Guangrong Zhou China 13 138 0.9× 77 1.0× 17 0.3× 34 0.6× 9 0.2× 31 410
Ziwei Hu China 16 228 1.4× 25 0.3× 33 0.5× 14 0.2× 43 0.8× 51 641
Cong Zhou China 15 183 1.2× 115 1.5× 33 0.5× 88 1.4× 4 0.1× 45 541
Zhe Jiang China 16 248 1.6× 36 0.5× 23 0.4× 33 0.5× 21 0.4× 60 578
Yanfei Jiang China 19 211 1.3× 33 0.4× 63 1.0× 45 0.7× 47 0.9× 59 778
Zhanqiang Li China 14 139 0.9× 48 0.6× 24 0.4× 25 0.4× 16 0.3× 52 520
Minjun Kim South Korea 10 82 0.5× 30 0.4× 34 0.5× 23 0.4× 10 0.2× 25 336

Countries citing papers authored by Lulu Ni

Since Specialization
Citations

This map shows the geographic impact of Lulu Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lulu Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lulu Ni more than expected).

Fields of papers citing papers by Lulu Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lulu Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lulu Ni. The network helps show where Lulu Ni may publish in the future.

Co-authorship network of co-authors of Lulu Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Lulu Ni. A scholar is included among the top collaborators of Lulu Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lulu Ni. Lulu Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ni, Lulu, et al.. (2024). Research on Chinese medicinal materials cultivation: A bibliometric and visual analysis. Heliyon. 10(7). e28637–e28637. 4 indexed citations
2.
Ni, Lulu, Ping Sun, Sujuan Zhang, et al.. (2023). Transcriptome and single-cell analysis reveal the contribution of immunosuppressive microenvironment for promoting glioblastoma progression. Frontiers in Immunology. 13. 1051701–1051701. 7 indexed citations
5.
Ni, Lulu & Manman Zhang. (2022). On the strategies of improving Russian teachers` ability: Taking the undergraduate excellent innovation class of Xi`an International Studies University as an example. Bulletin of the Moscow State Regional University (Linguistics). 27–35. 1 indexed citations
7.
Ni, Lulu, et al.. (2022). Berberine Inhibits FOXM1 Dependent Transcriptional Regulation of POLE2 and Interferes With the Survival of Lung Adenocarcinoma. Frontiers in Pharmacology. 12. 775514–775514. 13 indexed citations
8.
Ni, Lulu, Yajun Tang, Yangfan Nie, et al.. (2022). The Experimental Exploration of TCM Theory “Treating the Same Disease with Different Approaches” on an Ulcerative Colitis Model. Evidence-based Complementary and Alternative Medicine. 2022. 1–11. 2 indexed citations
9.
Wang, Ning, et al.. (2022). High-efficiency photovoltaic-thermoelectric hybrid energy harvesting system based on functionally multiplexed intelligent thermal management. Energy Conversion and Management. 272. 116377–116377. 28 indexed citations
10.
Sun, Jiangnan, Xiaoyi Yu, Bao Hou, et al.. (2021). Vaccarin enhances intestinal barrier function in type 2 diabetic mice. European Journal of Pharmacology. 908. 174375–174375. 17 indexed citations
11.
Zhou, Yuetao, Hong Chen, Min Ai, et al.. (2021). Type-1 Na+/H+ exchanger is a prognostic factor and associate with immune infiltration in liver hepatocellular carcinoma. Life Sciences. 278. 119613–119613. 6 indexed citations
12.
Hou, Bao, Jiangnan Sun, Min Ai, et al.. (2020). Preparation, characterization and wound healing effect of vaccarin-chitosan nanoparticles. International Journal of Biological Macromolecules. 165(Pt B). 3169–3179. 44 indexed citations
13.
Ni, Lulu, Weipao Miao, Chun Li, & Qingsong Liu. (2020). Impacts of Gurney flap and solidity on the aerodynamic performance of vertical axis wind turbines in array configurations. Energy. 215. 118915–118915. 56 indexed citations
14.
Zhou, Yuetao, Shuangshuang Li, Min Ai, et al.. (2020). 1,25(OH)2D3 mitigate cancer-related fatigue in tumor-bearing mice: Integrating network pharmacological analysis. Biomedicine & Pharmacotherapy. 128. 110256–110256. 8 indexed citations
15.
Shi, Xuelin, Zhongjie Li, Weiwei Cai, et al.. (2019). Chemical Constituents from Albiziae Cortex and Their Ability to Ameliorate Steatosis and Promote Proliferation and Anti-Oxidation In Vitro. Molecules. 24(22). 4041–4041. 7 indexed citations
16.
Xu, Fei, Yixiao Liu, Xuexue Zhu, et al.. (2019). Protective Effects and Mechanisms of Vaccarin on Vascular Endothelial Dysfunction in Diabetic Angiopathy. International Journal of Molecular Sciences. 20(18). 4587–4587. 34 indexed citations
17.
Ni, Lulu, et al.. (2017). Coptis Chinensis affects the function of glioma cells through the down-regulation of phosphorylation of STAT3 by reducing HDAC3. BMC Complementary and Alternative Medicine. 17(1). 524–524. 11 indexed citations
18.
Ni, Lulu, Lixin Wang, Chao Yao, et al.. (2017). The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3. Scientific Reports. 7(1). 45266–45266. 55 indexed citations
19.
Luo, Yingbin, Jianchun Wu, Xiaowen Zhu, et al.. (2016). NK Cell-Dependent Growth Inhibition of Lewis Lung Cancer by Yu-Ping-Feng, an Ancient Chinese Herbal Formula. Mediators of Inflammation. 2016. 1–7. 23 indexed citations
20.
Gong, Chenyuan, Chao Yao, Xiaowen Zhu, et al.. (2015). A High-Throughput Assay for Screening of Natural Products that Enhanced Tumoricidal Activity of NK Cells. Biological Procedures Online. 17(1). 12–12. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026